UPDATE 1-FDA expands approval of Merck's Keytruda to lung cancer
October 02, 2015 at 14:45 PM EDT
Oct 2 (Reuters) - The U.S. Food and Drug Administration on Friday granted accelerated approval for Merck & Co's immunotherapy, Keytruda, in patients with advanced non-small cell lung cancer, the most common form of the disease.
